SERA PROGNOSTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SERA PROGNOSTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 24.57K shares, a 4634.30% increase year-over-year.
- SERA PROGNOSTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 12.02K shares, a 73.85% decline year-over-year.
- SERA PROGNOSTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 39.84K shares, a 73.29% decline year-over-year.
- SERA PROGNOSTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 222.31K shares, a 251.19% increase year-over-year.
- SERA PROGNOSTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 308.62K shares, a 72.01% decline from fiscal 2024.
- SERA PROGNOSTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 1.10M shares, a 85.89% increase from fiscal 2023.
- SERA PROGNOSTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 593.09K shares, a 143.25% increase from fiscal 2022.
- SERA PROGNOSTICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 243.82K shares, a 53.49% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 24.57K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | 298.74K shares derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 12.02K shares 10-Q · filed 2026-05-06 | 274.68K shares derived: sum of 4 quarters · filed 2026-05-06 |
| 2025-12-31 | 39.84K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | 308.62K shares 10-K · filed 2026-03-18 |
| 2025-09-30 | 222.31K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 417.94K shares derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | 519.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | 258.93K shares derived: sum of 4 quarters · filed 2025-08-06 |
| 2025-03-31 | 45.95K shares 10-Q · filed 2025-05-07 | 722.71K shares derived: sum of 4 quarters · filed 2025-05-07 |
| 2024-12-31 | 149.16K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | 1.10M shares 10-K · filed 2025-03-19 |
| 2024-09-30 | 63.30K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | 1.29M shares derived: sum of 4 quarters · filed 2024-11-06 |
| 2024-06-30 | 464.31K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | 1.36M shares derived: sum of 4 quarters · filed 2024-08-07 |
| 2024-03-31 | 425.75K shares 10-Q · filed 2024-05-08 | 1.01M shares derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-12-31 | 333.15K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | 593.09K shares 10-K · filed 2024-03-20 |
| 2023-09-30 | 138.01K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | 260.91K shares derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-06-30 | 117.84K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 147.89K shares derived: sum of 4 quarters · filed 2023-08-09 |
| 2023-03-31 | 4.09K shares 10-Q · filed 2023-05-10 | 124.45K shares derived: sum of 4 quarters · filed 2023-05-10 |
| 2022-12-31 | 967.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | 243.82K shares 10-K · filed 2023-03-22 |
| 2022-09-30 | 24.99K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 317.89K shares derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | 94.39K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | 437.77K shares derived: sum of 4 quarters · filed 2022-08-10 |
| 2022-03-31 | 123.47K shares 10-Q · filed 2022-05-10 | |
| 2021-12-31 | 75.04K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | 524.24K shares 10-K · filed 2022-03-29 |
| 2021-09-30 | 144.87K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |